
TORNTPHARM.NS Technical Analysis Summary (NSE)
Analyze TORNTPHARM.NS on the NSE with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerTORNTPHARM.NS Technical Analysis Summary (NSE)
Torrent Pharmaceuticals Limited (NSE: TORNTPHARM.NS) stock currently shows a neutral trend on the NSE, supported by momentum and balanced buying pressure.
Technical conditions suggest Torrent Pharmaceuticals Limited on the NSE is awaiting a decisive move. Overall, Torrent Pharmaceuticals Limited remains neutral, with indicators showing mixed momentum.
RSI (14): 50.68
Stochastic %K: 34.02
Williams %R: -51.60
Rate of Change (ROC): 1.65
Takeaway:Torrent Pharmaceuticals Limited shows neutral momentum, with indicators pointing to indecision.
MACD: -10.95
ADX: 19.89
ATR (14): 94.67
CCI (14): -37.64
Takeaway:Torrent Pharmaceuticals Limited shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Torrent Pharmaceuticals Limited trades closer to resistance, supported by stronger momentum within bands.
Takeaway:Torrent Pharmaceuticals Limited trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:TORNTPHARM.NS shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
RSI above 50 → positive momentum from buyers.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
No significant bearish signals detected.
Overall Recommendation:Technical indicators for Torrent Pharmaceuticals Limited are mixed, suggesting a Hold or wait-and-see approach.